Skip to content
Screener

Delcath Systems DCTH Total Operating Expenses

Total Operating Expenses at other companies

Merit Medical Systems logo
Merit Medical SystemsMMSI
$140.64M+7.4%
Boston Scientific logo
Boston ScientificBSX
$2.51B+9.8%
Altimmune logo
AltimmuneALT
$24.24M+11.1%
Wave Life Sciences logo
Wave Life SciencesWVE
$76.07M+23.8%
CTO
Citius Oncology, Inc.CTOR
$29.95M+301%
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
$218.78M+64.8%

Other financials

Income statement

See full
Revenue$29.1M+20.6%
Gross profit$26.1M+25.5%
Operating income$2.4M-7.5%
Net income$2.7M-1.1%
EPS (diluted)$0.070.0%

Balance sheet

See full
Cash & equivalents$47.5M+38.0%
Total debt$2.5M+148%
Total equity$121.1M+15.4%
Total assets$137.0M+17.2%

Cash flow

See full
Operating cash flow$5.7M-21.7%
CapEx$503.0K+26.4%
Free cash flow$5.2M-24.5%

Valuation

See full
Market cap$578.43M+57.3%
Enterprise value$533.39M+59.6%
P/E112.9×
P/S6.1×+0.8×

Profitability

See full
Gross margin87.1%+1.2pp
Operating margin-118.1%-56.8pp
Net margin1.5%+0.8pp
FCF margin18.3%+12.8pp

Returns & leverage

See full
Return on equity1.9%+1.0pp
Debt / equity0.0×
Current ratio9.8×-1.0×

Where this comes from

Reported directly by Delcath Systems in its filing.

Tagged under the XBRL concept us-gaap:OperatingExpenses.

The source filing: Delcath Systems’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 9:09 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-053956
Line itemThree months ended June 30, 2026Three months ended June 30, 2025Six months ended June 30, 2026Six months ended June 30, 2025
Operating expenses:
Research and development expenses10,3806,88220,20411,889
Selling, general and administrative expenses13,37311,36626,44422,656
Total operating expenses23,75318,24846,64834,545
Operating income2,3952,5907583,232
Interest income7816491,5681,267
Other expense(17)(34)(75)(30)
Income before income taxes3,1593,2052,2514,469

Item 1. Financial Statements

FAQ

What is Delcath Systems's total operating expenses?
Delcath Systems (DCTH) reported total operating expenses of $23.75M in Q2 2026.
How has Delcath Systems's total operating expenses changed year-over-year?
Delcath Systems's total operating expenses increased by 30.2% year-over-year, from $18.25M to $23.75M.
What is the long-term trend for Delcath Systems's total operating expenses?
Over 4 years (2021 to 2025), Delcath Systems's total operating expenses has grown at a 27.6% compound annual growth rate (CAGR), from $27.41M to $72.77M.
What does total operating expenses mean?
The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.

Ask your AI about Delcath Systems's total operating expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude